Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people picking up their first Mounjaro KwikPen expect the process to feel complicated. It isn't. Each pen is pre-filled and pre-set, so there's no drawing up, no mixing and no dial to turn — the dose is locked in from the moment it leaves our pharmacy. What you do need is a clear, unhurried run-through of the steps, because Mounjaro is a prescription-only medicine and using it correctly matters for both safety and results. This guide walks you through everything, from taking the pen out of the fridge to disposing of the needle safely.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common concern our prescribers hear is that self-injecting must be technically demanding. In practice, the KwikPen was designed so patients can use it at home without clinical training. There's no visible needle to look at before or after the injection, no plunger to push and no dose to calculate. You attach a covered needle cap, press the pen against your skin and press the button. The device does the rest.
The misconception that causes real problems is treating the pen like something adjustable or pausable. Once you press the button, the full pre-set dose is delivered. This is why the injection site matters: the skin needs to be clean, pinch-able and free of bruising or redness from a previous injection. Rushing that check is the step most people skip on their first attempt.
Understanding how tirzepatide works in the body can also help you make sense of why timing and technique matter, the medicine acts on two gut-hormone receptors, and consistent weekly dosing is what keeps those levels steady.
Take the pen from the fridge about 30 minutes before you plan to inject. A pen still cold from the fridge door can sting more going in; letting it reach room temperature first makes a noticeable difference. While you wait, wash your hands thoroughly with soap and water.
Check the pen window: the liquid should be clear to slightly yellow and free of particles. If it looks cloudy or contains floating matter, don't use it, contact the pharmacy. Remove the pen cap, then attach a fresh needle by pressing the needle cap firmly onto the pen tip and turning clockwise. Remove the outer needle cap (keep it for recapping later) and then the inner cap, which you can discard.
Choose your site (abdomen (at least 5 cm from the navel), outer thigh or upper arm) and clean it with an alcohol swab, letting it dry for a few seconds. Pinch a fold of skin, press the pen firmly against it so the safety ring depresses, then press the injection button. Hold it in place for at least 10 seconds after the click; this ensures the full dose is delivered. Replace the outer needle cap, remove the needle from the pen and drop it straight into a sharps container. Never into the household bin.
The NHS tirzepatide medicines page provides a patient-level overview of what to expect, including a summary of injection technique.
The most commonly reported side effects are gastrointestinal: nausea, loose stools, constipation or indigestion, particularly in the first week or two after starting or after a dose step-up. For most people these settle as the body adjusts. Eating smaller meals and avoiding very fatty or rich food on injection day can help. Staying well hydrated matters too, because persistent vomiting or diarrhoea can tip into dehydration quickly.
Some tenderness or mild redness at the injection site is normal and usually fades within a day. Rotating your site each week (abdomen one week, thigh the next, upper arm the next) reduces the chance of a lump or thickened patch developing under the skin.
Seek urgent medical attention for severe, persistent stomach pain that spreads to the back, with or without vomiting. This is the symptom pattern associated with pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines in January 2026. It's uncommon, but it's the side effect that warrants calling 999 or going straight to A&E rather than waiting for a pharmacy callback.
If you have questions about a specific reaction, or if something doesn't feel right between doses, our aftercare team is available seven days a week. You can also find broader context on the Mounjaro treatment page or browse the common questions our prescribers field most often. For a look at the evidence behind the medicine's weight-loss results, the SURMOUNT trial data is worth reading.
This guide covers technique and general expectations. It doesn't cover your specific dose, when to move to the next strength, or what to do if you miss a week, those decisions belong to your prescriber and to the Patient Information Leaflet that comes with your pen. Mounjaro is a prescription-only medicine; the clinical assessment that precedes it exists precisely because the right dose and timing are individual, not universal.
If you're weighing up whether tirzepatide is right for you, or you'd like to understand what the weight-loss evidence realistically looks like at an individual level, those questions are exactly what a consultation is for. You can also find an overview of all weight-management treatment options at our treatment overview. Patients based in the north-west can read about the Manchester Mounjaro trial to see how local access to the treatment has been studied. When you're ready to take the next step, check your eligibility with our prescribers, and if you'd like to explore the wider research landscape, our page covering the tirzepatide trial UK data sets out what the clinical studies have shown in a British context.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.